Percutaneous Nephrostomy in Patients with Tumors of Advanced Stage: Treatment Dilemmas and Impact on Clinical Course and Quality of Life
Authors:
- 1 November 2007
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 21 (11) , 1297-1302
Abstract
The purpose of this study was to evaluate the outcome, in respect to safety, survival, and quality of life (QoL), after performance of percutaneous nephrostomy in patients with obstructive nephropathy caused by various types of advanced malignancy. A cohort of 270 patients with established nephropathy because of advanced pelvic or nonpelvic tumors was evaluated. A decision to obtain percutaneous access was made; primary stenting had either failed or was not feasible because of complicated anatomy. Patients were divided in equal groups by type of malignancy (54 patients each). In addition, each malignancy group was further divided in two equal subgroups by tumor burden (27 patients each). Correlations were made with respect to renal function outcome, overall survival after the procedure, and QoL differences both before and after the procedure. No serious complications, such as severe bleeding or sepsis, were experienced because of the procedure. Statistical analysis showed no significant differences in survival among patients with different types of cancer. Only patients with prostate (P < 0.0365) and colorectal (P < 0.0307) cancer with lower tumor burden had significantly longer survival when compared with patients with large tumor burden. Regarding QoL scores, only patients with prostate cancer in the subgroup with low tumor burden demonstrated a positive statistically significant difference (P < 0.001). Despite the fact that percutaneous nephrostomy has shown good safety characteristics and beneficial impact on renal function, only patients with specific cancers most likely to respond to ongoing palliative therapy or with cancers that progress slowly by nature may statistically benefit from the procedure. This questions the universal application of this procedure for all types and stages of advanced malignancy.Keywords
This publication has 12 references indexed in Scilit:
- Bladder cancer with obstructive uremia: Oncologic outcome after definitive surgical managementUrology, 2005
- Prognostic significance of obstructive uropathy in advanced prostate cancerUrology, 2004
- Surgical management of the urinary tract in patients with locally advanced colorectal cancerUrology, 2002
- Percutaneous Nephrostomy in the Management of Malignant Ureteral Obstruction Secondary to Bladder CancerJournal of Endourology, 2001
- Outcome of palliative urinary diversion in the treatment of advanced malignanciesCancer, 1999
- Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancerArchives of Gynecology and Obstetrics, 1997
- Komplikationen bei perkutaner NephrostomieeinlageAktuelle Urologie, 1994
- Invasive Bladder Cancer and Uremia: Dilemma in ManagementJournal of Urology, 1993
- The role of percutaneous nephrostomy in malignant urinary tract obstructionClinical Radiology, 1993
- High Failure Rate of Indwelling Ureteral Stents in Patients with Extrinsic Obstruction: Experience at 2 InstitutionsJournal of Urology, 1989